Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Receivables (2024 - 2025)

Korro Bio's Change in Receivables history spans 2 years, with the latest figure at $149000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 91.21% year-over-year to $149000.0, compared with a TTM value of -$727000.0 through Dec 2025, down 142.87%, and an annual FY2025 reading of -$727000.0, down 142.87% over the prior year.
  • Change in Receivables for Q4 2025 was $149000.0 at Korro Bio, up from -$269000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $1.7 million in Q4 2024, with the low at -$835000.0 in Q2 2025.